Investor Insights from CEOs & CFOs | Financial Results & Presentations | seat11a

Amadeus Fire AG H1 2026: Key Takeaways

In this financial results presentation on seat11a, Jörg Peters, Head of Investor Relations at Amadeus Fire AG, presents the company’s Q2 and First Half 2026 Financial Results and discusses developments across its Personnel Services and Training segments.

Q2 and First Half 2026 Financial Performance

The first half of 2026 remained challenging for Amadeus Fire as Germany’s weak economic environment continued to impact recruitment activity and corporate hiring decisions. Group revenue declined by 8.0% to €171.7 million, while operating EBITA decreased to €3.5 million and net income amounted to €-3.6 million. Personnel Services continued to face weaker demand, particularly in permanent placement, while the Training segment once again demonstrated resilience through higher revenues and improved profitability.

Personnel Services and Training Segment Developments

Within Personnel Services, companies remained cautious regarding recruitment due to economic uncertainty, delayed investment decisions, and a weaker labour market. Seasonal effects and lower permanent placement activity further affected profitability during the second quarter. At the same time, the Training segment benefited from continued demand for vocational education, public training programmes, and corporate learning solutions, with acquisitions contributing additional revenue growth.

AI First Strategy and Digital Transformation

A central topic of the presentation is the company’s strategic AI First approach. Amadeus Fire continues to integrate artificial intelligence into recruitment, training, knowledge management, onboarding, and corporate learning through AI-powered platforms, Agentic AI services, and scalable SaaS solutions. Management sees AI as an important driver for increasing productivity, strengthening customer relationships, and expanding digital education offerings.

Updated FY 2026 Guidance and Long-Term Positioning

Following the weaker second quarter, management revised its FY 2026 guidance and now expects revenue between €350 million and €365 million and operating EBITA between €17 million and €23 million. The company continues to focus on productivity improvements, cost discipline, digital transformation, and AI-supported solutions while positioning itself to benefit from Germany’s long-term structural shortage of skilled labour.

▶️ Other videos:

Elevator Pitch: https://seat11a.com/investor-relations-elevator-pitch/

Company Presentation: https://seat11a.com/investor-relations-company-presentation/

Deep Dive Presentation: https://seat11a.com/investor-relations-deep-dive/

Financial Results Presentation: https://seat11a.com/investor-relations-financial-results/

ESG Presentation: https://seat11a.com/investor-relations-esg/

T&C

This publication is for informational purposes only and does not constitute investment advice. Using this website, you agree to our terms and conditions outlined on www.seat11a.com/legal and www.seat11a.com/imprint.

Wacker Chemie AG Q1 2026: Key Takeaways

WACKER Chemie AG First Half 2026 Financial Results Presentation

In this financial results presentation on seat11a, Jörg Hoffmann, Head of Investor Relations at WACKER Chemie AG, presents the company’s First Half 2026 Financial Results and discusses financial performance, business segment developments, operational improvements, and the updated outlook for the year.

First Half 2026 Financial Performance

During the second quarter of 2026, WACKER increased sales by 7% year-on-year to €1.52 billion. Reported EBITDA rose to €211 million, while EBITDA before special effects reached €175 million, supported by higher volumes, improved pricing, and continued savings from the company’s PACE efficiency program. Net income increased significantly to €350 million, primarily reflecting Siltronic-related valuation and transaction effects.

Chemicals, Biosolutions and Polysilicon Business Developments

The Chemicals division delivered strong operational performance across both Silicones and Polymers. Higher volumes, price increases to offset raw material inflation, and operational improvements supported higher profitability, while Biosolutions continued to benefit from BioPharma project business and disciplined cost management. The Polysilicon business continued to benefit from strong semiconductor demand, although solar markets remained challenging due to weak pricing, Chinese overcapacity, and regulatory uncertainty in the United States.

PACE Efficiency Program Driving Operational Improvements

A major focus of the presentation is the company’s PACE efficiency program, which continues to improve operational performance across the Group. Management highlighted approximately €45 million of savings achieved during the quarter and reaffirmed the long-term target of generating more than €300 million in cumulative annual savings by 2028.

Strong Balance Sheet and Updated FY 2026 Outlook

The presentation also highlights WACKER’s strong financial position. Liquidity remained high at €1.57 billion, shareholder equity increased to €4.18 billion, and net financial debt declined to €722 million. Following the stronger first-half performance, management raised its FY 2026 EBITDA guidance to €625–750 million while maintaining expectations for mid-single-digit sales growth during the year.

▶️ Other videos:

Elevator Pitch: https://seat11a.com/investor-relations-elevator-pitch/

Company Presentation: https://seat11a.com/investor-relations-company-presentation/

Deep Dive Presentation: https://seat11a.com/investor-relations-deep-dive/

Financial Results Presentation: https://seat11a.com/investor-relations-financial-results/

ESG Presentation: https://seat11a.com/investor-relations-esg/

T&C

This publication is for informational purposes only and does not constitute investment advice. Using this website, you agree to our terms and conditions outlined on www.seat11a.com/legal and www.seat11a.com/imprint.

Palfinger AG Elevator Pitch: Key Takeaways

PALFINGER AG Elevator Pitch Presentation

In this Elevator Pitch on seat11a, Felix Strohbichler, CFO of PALFINGER AG, presents the company’s business model, competitive strengths, strategic priorities, and long-term growth ambitions.

Global Technology Leader in Crane and Lifting Solutions

PALFINGER is a global technology leader in crane and lifting solutions, serving customers across a wide range of industries through an extensive product portfolio, a global service network, and strong local market positions. The company’s strategy is built around technology leadership, operational resilience, sustainable shareholder value creation, and long-term profitable growth.

Four Pillars of the PALFINGER Equity Story

Management highlights four key pillars of the equity story. These include PALFINGER’s position as a technology and industry leader, the resilience created by its diversified products and global footprint, attractive growth opportunities across Europe, North America, APAC, Marine and services, and additional earnings potential through digitalization, standardization, and footprint optimization.

Regional Growth Opportunities and Market Developments

The presentation also reviews current regional developments. Strong momentum in Southern Europe, improving markets in Northern Europe, continued growth in India, and solid demand in the Marine business are offset by weaker market conditions in North America and China. This diversified geographic exposure contributes to the company’s resilience across different economic cycles.

Efficiency Program and 2030 Financial Targets

To further enhance profitability, PALFINGER has launched a comprehensive efficiency program expected to reduce structural costs by €25 million while keeping the cost base broadly stable despite inflation and continued growth. At the same time, management reaffirmed the company’s long-term 2030 financial targets, including revenue of more than €3 billion, an EBIT margin of 12%, ROCE of 15%, and the ambition to become the global leader in crane and lifting solutions.

Technology Leadership and Long-Term Value Creation

Overall, the presentation demonstrates how PALFINGER combines technology leadership, operational excellence, global diversification, and disciplined execution to support sustainable long-term growth and value creation.

 ▶️ Other videos:

Elevator Pitch: https://seat11a.com/investor-relations-elevator-pitch/

Company Presentation: https://seat11a.com/investor-relations-company-presentation/

Deep Dive Presentation: https://seat11a.com/investor-relations-deep-dive/

Financial Results Presentation: https://seat11a.com/investor-relations-financial-results/

ESG Presentation: https://seat11a.com/investor-relations-esg/

T&C

This publication is for informational purposes only and does not constitute investment advice. Using this website, you agree to our terms and conditions outlined on www.seat11a.com/legal and www.seat11a.com/imprint.

PALFINGER AG First Half 2026 Financial Results Presentation

In this financial results presentation on seat11a, Felix Strohbichler, CFO of PALFINGER AG, presents the company's First Half 2026 Financial Results and discusses financial performance, regional business developments, cash generation, balance sheet improvements, and the outlook for the remainder of the year.

First Half 2026 Financial Performance

PALFINGER generated revenue of €1.17 billion during the first half of 2026, representing year-on-year growth despite a mixed market environment. EBITDA reached €133.3 million, while EBIT amounted to €84.1 million and net profit totaled €48.0 million. Management explained that earnings were affected by weaker demand in North America, the Middle East, and Asia, while several European markets continued to perform well.

Regional Business Developments

Regional developments remained mixed across the Group. Southern Europe continued to deliver strong momentum, Northern Europe improved, India remained an important growth driver within APAC, and the Marine segment benefited from offshore wind and cruise projects. In contrast, tariffs weighed on demand in North America, China remained weak, and Russia continued to decline.

Operating Cash Flow and Balance Sheet Strength

A key highlight of the presentation is PALFINGER's stronger financial position. Operating cash flow increased to €68.8 million, while the company maintained its target of generating more than €100 million in free cash flow for the full year. Following the placement of treasury shares, the balance sheet improved significantly, with the equity ratio increasing to 43.6%, gearing falling to 55.7%, and net debt declining to €526.7 million.

Efficiency Program and Long-Term Strategy

Management also introduced a comprehensive efficiency program expected to reduce structural costs by €25 million, supporting future profitability while preserving the company's long-term growth ambitions. Although the achievement of the 2027 financial targets has been delayed by slower economic recovery in major markets, PALFINGER reaffirmed its 2030 strategy, targeting revenue above €3 billion, an EBIT margin of 12%, ROCE of 15%, and continued leadership in crane and lifting solutions.

 ▶️ Other videos:

Elevator Pitch: https://seat11a.com/investor-relations-elevator-pitch/

Company Presentation: https://seat11a.com/investor-relations-company-presentation/

Deep Dive Presentation: https://seat11a.com/investor-relations-deep-dive/

Financial Results Presentation: https://seat11a.com/investor-relations-financial-results/

ESG Presentation: https://seat11a.com/investor-relations-esg/

T&C

This publication is for informational purposes only and does not constitute investment advice. Using this website, you agree to our terms and conditions outlined on www.seat11a.com/legal and www.seat11a.com/imprint.

In diesem seat11a Elevator Pitch stellt Michael Schneiders, CFO der BRAIN Biotech AG, das Geschäftsmodell, die Technologieplattform und die langfristige Wachstumsstrategie des Unternehmens vor.BRAIN Biotech ist ein Unternehmen der industriellen Biotechnologie und entwickelt Enzyme, Mikroorganismen sowie biologische Lösungen für Kunden aus den Bereichen Lebensmittel, Getränke, Life Sciences sowie weiteren Spezialmärkten. Mit seinen Produkten unterstützt das Unternehmen die Biologisierung industrieller Prozesse und den Übergang zu nachhaltigeren Produktionsverfahren.Das Geschäftsmodell basiert auf zwei komplementären Säulen. BRAINBiocatalysts bündelt das operative Geschäft mit Spezialenzymen, Mikroorganismen sowie Forschungs-, Entwicklungs- und Produktionsdienstleistungen. BRAINBioIncubator konzentriert sich auf innovative Entwicklungsprojekte, Beteiligungen sowie Lizenz- und Royalty-Modelle mit zusätzlichem Wertschöpfungspotenzial.Im Geschäftsjahr 2024/25 erzielte BRAIN Biotech einen Umsatz von rund 45,4 Mio. Euro, ein bereinigtes EBITDA von rund 4,4 Mio. Euro sowie wiederkehrende Erlöse von rund 4,2 Mio. Euro. Damit verbindet das Unternehmen ein profitables operatives Geschäft mit langfristigen Innovationsprojekten.Im Rahmen des Capital Markets Day 2024 stellte BRAIN Biotech ambitionierte mittelfristige Ziele vor. Für den Bereich BRAINBiocatalysts strebt das Unternehmen einen Umsatz von 100 Mio. Euro sowie eine bereinigte EBITDA-Marge von 15 % an. Ergänzend soll die erfolgreiche Kommerzialisierung von Projekten aus dem BRAINBioIncubator zusätzliche Wertschöpfung schaffen.Langfristig verfolgt BRAIN Biotech das Ziel, zu den Top 10 der weltweit führenden Spezialenzymunternehmen aufzusteigen und von den strukturellen Wachstumstrends in den Bereichen industrielle Biotechnologie, Spezialenzyme und nachhaltige biologische Lösungen zu profitieren. ▶️ Other videos:Elevator Pitch: https://seat11a.com/investor-relations-elevator-pitch/Company Presentation: https://seat11a.com/investor-relations-company-presentation/Deep Dive Presentation: https://seat11a.com/investor-relations-deep-dive/Financial Results Presentation: https://seat11a.com/investor-relations-financial-results/ESG Presentation: https://seat11a.com/investor-relations-esg/T&CThis publication is for informational purposes only and does not constitute investment advice. Using this website, you agree to our terms and conditions outlined on www.seat11a.com/legal and www.seat11a.com/imprint.

Key Takeaways

BRAIN Biotech AG Elevator Pitch Presentation

In this seat11a Elevator Pitch, Michael Schneiders, CFO of BRAIN Biotech AG, presents the company’s business model, biotechnology platform, and long-term growth strategy.

Biotechnology Platform for Sustainable Industrial Solutions

BRAIN Biotech develops enzyme products, microorganisms, and biological solutions that help customers replace conventional industrial processes with more sustainable biotechnology-based alternatives. The company serves customers across food, beverage, life sciences, proteins, dairy, and other specialty industrial markets through its integrated biotechnology platform.

Two Complementary Business Pillars

The business is built around two complementary pillars. The BRAINBiocatalysts division develops and produces specialty enzymes and microbial solutions while providing contract research and manufacturing services. The BRAINBioIncubator focuses on breakthrough innovation projects, strategic participations, and pharmaceutical royalty opportunities that have the potential to create significant additional value over time.

Balanced Business Model and Financial Performance

Management explains how this combination creates a balanced business model, generating profitable operating revenues while maintaining exposure to higher-value innovation projects. During FY 2024/25, BRAIN Biotech generated approximately €45.4 million in annual revenue, €4.4 million adjusted EBITDA, and approximately €4.2 million in recurring revenues, providing a solid financial foundation for future growth.

Medium-Term Growth Targets and Expansion Strategy

Looking ahead, the company has set ambitious medium-term objectives presented at its 2024 Capital Markets Day. Within its BRAINBiocatalysts division, management targets €100 million in revenue together with an adjusted EBITDA margin of 15%, supported by organic growth and acquisitions. At the same time, BRAINBioIncubator continues to offer additional upside through the commercialization of innovative biotechnology projects.

Long-Term Growth Drivers in Industrial Biotechnology

The presentation also explains how BRAIN Biotech benefits from long-term structural trends including sustainable manufacturing, biologization of industrial processes, growing demand for specialty enzymes, and increasing adoption of biological solutions across multiple industries. Management’s long-term ambition is to establish BRAIN Biotech as one of the Top 10 global enzyme companies.

▶️ Other videos:

Elevator Pitch: https://seat11a.com/investor-relations-elevator-pitch/

Company Presentation: https://seat11a.com/investor-relations-company-presentation/

Deep Dive Presentation: https://seat11a.com/investor-relations-deep-dive/

Financial Results Presentation: https://seat11a.com/investor-relations-financial-results/

ESG Presentation: https://seat11a.com/investor-relations-esg/

T&C

This publication is for informational purposes only and does not constitute investment advice. Using this website, you agree to our terms and conditions outlined on www.seat11a.com/legal and www.seat11a.com/imprint.

eDreams ODIGEO's Deep Dive: Key Takeaways

eDreams ODIGEO Artificial Intelligence Deep Dive

In this deep dive presentation on seat11a, David Elizaga explains how Artificial Intelligence has become a core component of eDreams ODIGEO’s business model and long-term growth strategy.

Artificial Intelligence as a Core Business Component

Management describes eDreams as an AI-first company for more than a decade, emphasizing that AI has been integrated into the business long before the recent surge of interest in generative AI technologies. Today, AI supports multiple areas of the company, including customer acquisition, software development, customer service, pricing, marketing, and product innovation.

Prime Subscription Ecosystem and Proprietary Travel Platform

A central part of the strategy is the combination of the company’s proprietary travel platform and its Prime subscription ecosystem. With approximately 8 million Prime subscribers, eDreams benefits from a large base of repeat customers, reducing dependence on highly competitive performance marketing channels and creating a relationship-based customer model that management views as a significant competitive advantage.

Agentic AI and Customer Acquisition

The company also sees emerging opportunities through Agentic AI. Management believes AI-powered travel assistants could become an additional customer acquisition channel while simultaneously enhancing customer experience and strengthening product capabilities. eDreams expects AI to support future growth by improving personalization, customer interactions, and operational efficiency.

AI Productivity Gains in Software Development

The operational impact of AI is already visible across the organization. During FY26, AI-assisted development contributed to a 47% increase in productivity, while some engineering teams now generate code entirely through AI-assisted workflows that are subsequently reviewed by humans. Agentic development has enabled the company to deliver five times more business features than before.

AI in Customer Service and Cost Efficiency

Customer service has also benefited from AI adoption. Approximately 30% of support calls are now solved by AI, while customer satisfaction levels remain comparable to human-assisted interactions. In addition, AI-supported automation contributed to a 13% reduction in customer service costs during FY26.

AI-Driven Pricing and Marketing Capabilities

Across marketing and pricing, AI is increasingly used to optimize commercial activities. The company reported a 24% increase in AI-driven pricing capabilities, while AI-generated marketing content expanded significantly, helping reduce external production costs by 75% while maintaining a stable headcount.

Artificial Intelligence Supporting Long-Term Growth

Overall, the presentation demonstrates how eDreams ODIGEO is applying Artificial Intelligence across its business operations and how management sees AI supporting future innovation, productivity, customer engagement, and long-term growth.

▶️ Other videos:

Elevator Pitch: https://seat11a.com/investor-relations-elevator-pitch/

Company Presentation: https://seat11a.com/investor-relations-company-presentation/

Deep Dive Presentation: https://seat11a.com/investor-relations-deep-dive/

Financial Results Presentation: https://seat11a.com/investor-relations-financial-results/

ESG Presentation: https://seat11a.com/investor-relations-esg/

T&C

This publication is for informational purposes only and does not constitute investment advice. Using this website, you agree to our terms and conditions outlined on www.seat11a.com/legal and www.seat11a.com/imprint.

Matador AG Deep Dive: Key Takeaways

Matador Secondary Private Equity AG Deep Dive Presentation

In this deep dive presentation on seat11a, Alexander Lachmann, CFO of Matador Secondary Private Equity AG, explains how the company provides investors with access to a diversified private equity portfolio and a broad range of innovative private companies.

Diversified Private Equity Portfolio Built Over Two Decades

Over the past two decades, Matador has built a portfolio through investments with leading international private equity managers. The company focuses primarily on small and mid-market buyout strategies while selectively investing in venture capital and growth opportunities. This diversified approach provides exposure to more than one thousand underlying companies across numerous industries and regions.

SpaceX and Exposure to Innovative Private Companies

A key topic of the presentation is the company’s exposure to SpaceX, one of the world’s most talked-about private companies. Through its investment strategy, Matador participates in value creation generated by SpaceX alongside other innovative businesses such as Stripe, Revolut, Anduril Industries, and ByteDance. The presentation explains how these investments fit within the broader portfolio and how successful exits contribute additional capital for future investments.

Secondary Private Equity Investments and Market Access

The discussion also covers the role of secondary private equity investments and how Matador’s listed structure provides access to an asset class that is often difficult for individual investors to access directly. By combining diversification, manager selection, and long-term portfolio construction, the company has developed a private equity portfolio designed to participate in long-term value creation across global private markets.

Investment Philosophy and Portfolio Strategy

Overall, the presentation provides insight into Matador’s investment philosophy, portfolio composition, and approach to private equity investing.

▶️ Other videos:

Elevator Pitch: https://seat11a.com/investor-relations-elevator-pitch/

Company Presentation: https://seat11a.com/investor-relations-company-presentation/

Deep Dive Presentation: https://seat11a.com/investor-relations-deep-dive/

Financial Results Presentation: https://seat11a.com/investor-relations-financial-results/

ESG Presentation: https://seat11a.com/investor-relations-esg/

T&C

This publication is for informational purposes only and does not constitute investment advice. Using this website, you agree to our terms and conditions outlined on www.seat11a.com/legal and www.seat11a.com/imprint.

Amoeba SA Elevator Pitch: Key Takeaways

Amoéba SA Elevator Pitch Presentation

In this Elevator Pitch on seat11a, Jean-François Doucet, CEO of Amoéba SA, presents the company’s strategy, technology platform and commercial development plans across agriculture and cosmetics.

A Green Technology Company Built on Proprietary Amoeba Cultivation

Amoéba is a French green technology company specializing in natural bio-solutions derived from proprietary amoeba cultivation technology. The company has spent more than a decade developing a unique industrial platform and has built a portfolio of intellectual property, industrial expertise and commercial partnerships designed to support future growth.

Biological Crop Protection and Sustainable Agriculture

The company’s agricultural activities focus on biological crop protection products designed to offer natural alternatives to conventional chemical solutions. Regulatory milestones have already been achieved, including active substance approval in Europe and product authorization in the United States. These achievements provide the foundation for commercial deployment through strategic partnerships with major industry participants.

Strategic Partnerships with Koppert and Syngenta

Amoéba has signed an exclusive distribution agreement with Koppert for selected crop applications and has established a memorandum of understanding with Syngenta focused on future cereal opportunities. These partnerships provide access to large agricultural markets while leveraging established commercial infrastructures.

Natural Cosmetic Ingredients and Well-Ageing Solutions

The company is also developing a natural cosmetic ingredient targeting skin protection, repair and well-ageing applications. Through partnerships in China and international commercialization efforts, management sees cosmetics as an additional long-term growth driver supported by attractive market dynamics and higher-margin opportunities.

Transition from Development to Commercial Execution

Throughout the presentation, management emphasizes that Amoéba is transitioning from a development-stage story toward commercial execution. With technology validation, regulatory approvals, industrial partners and commercial agreements already in place, the company believes it is entering a new phase focused on market adoption and growth.

▶️ Other videos:

Elevator Pitch: https://seat11a.com/investor-relations-elevator-pitch/

Company Presentation: https://seat11a.com/investor-relations-company-presentation/

Deep Dive Presentation: https://seat11a.com/investor-relations-deep-dive/

Financial Results Presentation: https://seat11a.com/investor-relations-financial-results/

ESG Presentation: https://seat11a.com/investor-relations-esg/

T&C

This publication is for informational purposes only and does not constitute investment advice. Using this website, you agree to our terms and conditions outlined on www.seat11a.com/legal and www.seat11a.com/imprint.

eDreams ODIGEO's FY 2026 Key Takeaways

Presented by David Elizaga, CFO

In this latest financial results presentation on seat11a, David Elizaga presents the company’s FY 2026 financial results and provides an update on Prime subscriber growth, profitability development, artificial intelligence initiatives, and the company’s long-term strategic roadmap.

Record Profitability and Continued Prime Growth

eDreams ODIGEO delivered results ahead of expectations during FY26, supported by continued growth of its Prime subscription platform. Prime membership increased by 9% to 7.9 million subscribers, while Adjusted EBITDA rose by 29% to a record €172.3 million. Cash EBITDA reached €157 million, exceeding management’s target for the year. Prime-related revenue now represents approximately 75% of total Cash Revenue Margin, underlining the growing importance of the subscription model within the business and the continued transformation away from a traditional online travel agency model.

Prime Platform Remains the Core Growth Engine

A major focus of the presentation is the continued evolution of the Prime platform. During FY26, the company continued its transition from annual upfront subscription payments toward annual subscriptions with monthly instalments. While this temporarily impacted certain cash metrics, management highlighted that the underlying profitability, subscriber economics, and operational performance of the business continued to strengthen throughout the year. The subscription-based model remains central to eDreams’ strategy of increasing customer loyalty, recurring revenue visibility, and long-term customer lifetime value.

FY30 Roadmap Targets Significant Expansion

The company also introduced a new long-term roadmap extending through FY30. Management outlined plans for substantial subscriber growth, expanding Prime membership toward approximately 13 million subscribers while continuing to broaden the business beyond its traditional European flight market. By FY30, management expects a significantly more diversified business mix, supported by growth in non-flight products, international opportunities, and a broader travel ecosystem. The roadmap reflects the company’s ambition to further strengthen its position as a subscription-led travel platform with increasing scale and recurring revenue characteristics.

Artificial Intelligence Increasingly Embedded Across the Business

Artificial intelligence remains a key component of the company’s operating model. eDreams highlighted more than a decade of AI development and discussed how AI is improving software development, customer service, pricing capabilities, marketing productivity, and customer acquisition. During FY26, AI-assisted productivity increased significantly, while support automation and content generation continued to scale across the organization. Management views artificial intelligence as both an operational efficiency tool and a strategic enabler that can support customer experience improvements, marketing effectiveness, and scalable growth over the long term.

Read more on: https://seat11a.com/company/edreams-odigeo-financial-results-fy-2026/

▶️ Other videos:

Elevator Pitch: https://seat11a.com/investor-relations-elevator-pitch/

Company Presentation: https://seat11a.com/investor-relations-company-presentation/

Deep Dive Presentation: https://seat11a.com/investor-relations-deep-dive/

Financial Results Presentation: https://seat11a.com/investor-relations-financial-results/

ESG Presentation: https://seat11a.com/investor-relations-esg/

T&C

This publication is for informational purposes only and does not constitute investment advice. Using this website, you agree to our terms and conditions outlined on www.seat11a.com/legal and www.seat11a.com/imprint.